ESG2 Sept 2026, 06:21 pm
AstraZeneca India Gets Independent ESG Rating of 64
AI Summary
AstraZeneca Pharma India Ltd has received an independent Environmental, Social, and Governance (ESG) rating of 64 from Crisil ESG Ratings & Analytics Limited. This rating is based on publicly available information for fiscal year 2026. The company has clarified that it did not engage Crisil ESG Ratings for this assessment, and the rating was prepared independently by Crisil based on the company's publicly disclosed data. This disclosure provides stakeholders with an external perspective on the company's ESG performance.
Key Highlights
- Independent ESG rating of 64 assigned by Crisil.
- Rating based on publicly available data for FY26.
- Company did not engage Crisil for the rating.
- Crisil prepared the report independently.
- Disclosure provides external ESG performance insight.
Price Impact
More from ASTRAZEN